Director
CurrentAt A&M, provide support to Private Equity clients by developing financial transparency into the operations of their portfolio companies, including identifying and implementing performance improvement initiatives across a wide range of industries. Recent Client Engagements include:- Served as Interim/Project Controller for Client's involvement in 'Operation Warp Speed' in support of the US Government initiative to distribute COVID-19 Vaccines. Developed Project Budget and worked daily with CEO/COO to manage financial impacts of a complex/rapidly changing Supply Chain - Including the fast-track construction of a new manufacturing facility to supply cold-temperature packaging for Vaccine shipments that resulted in the doubling of client’s revenue from ~$100M to $200M- Lead Client Engagement to develop financial transparency into Product / Customer profitability for a Frozen Food Distributor. Identified areas of complexity that drove increased operational cost and developed pricing tool to adequately charge customers based on complexity of order fulfilment, resulting in 20% EBITDA Improvement- Other notable Client Engagements include developing network optimization strategy that led to footprint consolidation for a ~$1B Air Ambulance Operator (~$70M EBITDA Improvement), Implemented Cost Take-Out strategy for ~$1.8B Publicly Traded Home-Products Company to right-size cost structure in response to COVID-related Revenue Decline (~$45M Cost Savings) and development of EBITDA improvement plan for national Data Center Operator to ensure debt covenant compliance. Additionally, supported numerous Private Equity clients with pre-acquisition operational due diligence to identify and quantify synergy / cost savings opportunity for potential acquisition targets
